Based upon the presence or absence of molecular markers for estrogen or progesterone receptors (ER or PR) and human epidermal growth factor 2 (HER2), breast cancer can be divided into three crucial subtypes: hormone receptor-positive, HER2-positive and triple-negative breast cancer [2]. This evidence concerns the gene ERBB2 and breast carcinoma.